Discovery of nanomolar phosphoinositide 3-kinase gamma (PI3Kγ) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis
- 1 September 2014
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 84, 454-465
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Efficient Stacking on Protein Amide FragmentsChemMedChem, 2013
- Docking Studies on Isoform-Specific Inhibition of Phosphoinositide-3-KinasesJournal of Chemical Information and Modeling, 2010
- Tumours with PI3K activation are resistant to dietary restrictionNature, 2009
- Design and synthesis of phenethyl benzo[1,4]oxazine-3-ones as potent inhibitors of PI3KinaseγBioorganic & Medicinal Chemistry Letters, 2007
- Expect the Unexpected or Caveat for Drug Designers: Multiple Structure Determinations Using Aldose Reductase Crystals Treated under Varying Soaking and Co-crystallisation ConditionsJournal of Molecular Biology, 2006
- Action mechanisms and structure–activity relationships of PI3Kγ inhibitors on the enzyme: a molecular modeling studyEuropean Journal of Medicinal Chemistry, 2006
- PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patientsCancer Cell, 2004
- Heterogeneity and Inaccuracy in Protein Structures Solved by X-Ray CrystallographyStructure, 2004
- Molecular shape and the prediction of high-performance liquid chromatographic retention indexes of polycyclic aromatic hydrocarbonsAnalytical Chemistry, 1987
- A simple method for the representation, quantification, and comparison of the volumes and shapes of chemical compoundsJournal of Chemical Information and Computer Sciences, 1986